Vol. 2 No. 1 (2020)

• Masthead

  1-6

  • PDF

Editorial

• An immunization program against the COVID-19 infodemic

  Luis Cláudio Correia, João de Deus Barreto Segundo

  7-9

  • PDF

Research Articles

• Physicians’ preference towards the non-evidence based hydroxychloroquine treatment for COVID-19: the pandemic effect

  Luis Claudio Correia, João Ricardo Pinto Lopes, Flávia Barreto Garcez, Edmond Le Campion, Guilherme Barcellos, José Augusto Barreto-Filho

  10-15

  • PDF

Choosing Wisely

• Using resources wisely in the COVID-19 pandemic: an international list of Choosing Wisely recommendations

  Karen Born, Wendy Levinson, Luis Claudio Correia, Sandra Vernero

  16-21

  • PDF

Thought Experiments

• A cloroquina e o paraquedas: uma fábula da era COVID19

  Renato Gorga Bandeira de Mello

  93-96

  • PDF (Portuguese)
  • PDF

Concept Articles

• Study publication date should not dictate suitability of methodological and reporting quality assessment

  Rafael Leite Pacheco, Luis Eduardo Santos Fontes, Enderson Miranda, Ana Luiza Cabrera Martimbianco, Rachel Riera

  22-24

  • PDF

• Why COVID-19 trials should be blinded (as any other one)

  Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Carolina de Oliveira Cruz Latorraca, Rachel Riera

  25-27

  • PDF

• Hydroxychloroquine for the treatment of COVID-19: an approach based on the philosophy of science and heuristics

  Davi Jorge Fontoura Solla

  28-31

  • PDF

• A safety profile is sufficient for using a drug?

  Rodrigo S Biondi, Luis Cláudio Correia

  32-34

  • PDF

• Ensaios clínicos são mais difíceis de serem conduzidos em covid-19 do que em outras condições?

  Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Raphael Einsfeld Simões Ferreira, Rachel Riera

  35-37

  • PDF (Portuguese)

• Glucocorticoid for croup in children

  Jeffrey Hom, Ambreen S Khan

  38-40

  • PDF

• Evidence-based health and the judicialization of health in Brazil

  Vania dos Santos Nunes-Nogueira, Mauro Salles Ferreira Leite

  41-44

  • PDF (Portuguese)
  • PDF

• The costly hydroxychloroquine battle in Brazil

  Felipe Nogueira, Josikwylkson Costa Brito

  45-47

  • PDF

• Potential treatments for COVID-19 are not parachutes – avoiding a pandemic of medical reversals

  Alison Felipe Alencar Chaves, Felipe Nogueira

  48-50

  • PDF

• Do pandemics justify non-evidence-based therapies?

  Luís Cláudio Lemos Correia, John Mandrola

  51-53

  • PDF

Critical Appraisal of Evidence

• Markers of fluid responsiveness in hemodynamically unstable patients

  Jia Jian Li, James Hassel, Joel Gernsheimer

  54-56

  • PDF

• Inhaled steroids for asthma after emergency department discharge

  John Z Hillenkamp, Allan B Wolfson

  57-59

  • PDF

• Antiarrhythmics in patients with out-of-hospital-cardiac arrest do not improve survival to hospital discharge

  Robert Allen, Peter Tepler, Ian deSouza

  60-62

  • PDF

Systematic Reviews

• Hydroxychloroquine and chloroquine for COVID-19 infection. Rapid systematic review

  Rafael Leite Pacheco, Rachel Riera

  74-92

  • PDF

Registered Reports

• Study protocol to evaluate cardiovascular disease prevention and control programs in an oil company

  Maria Lúcia Ribeiro Rocha, Ana Marice Teixeira Ladeia

  63-73

  • PDF (Portuguese)
  • PDF

Bridging the gap

• Spin: modificações na redação científica que escondem fragilidades metodológicas com impacto social negativo

  Charles Lucena Alves, Gabriel Gonçalves da Costa, João de Deus Barreto Segundo, Lucas Helal

  97-105

  • PDF (Portuguese)

• Do in vitro ao in vivo: a eficácia da cloroquina no tratamento da COVID-19

  Filipe Mosca Guerra

  106-111

  • PDF (Portuguese)